Clear Cell Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Sorry, in progress, not accepting new patients
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.
San Francisco 5391959, California 5332921 and other locations
Last updated: